© 2026 CellCarta - All rights reserved.
Early-stage programs can’t afford delays or uncertain results. Our Lake Forest laboratory delivers rapid, high-quality biomarker and pathology data — so your team can move forward with confidence.
The rigor and quality of your early-stage programs play a defining role in the success of your therapeutic development. Our Lake Forest laboratory offers the histopathology services needed to make rapid, confident decisions — while ensuring the transition to global later-stage programs is seamless.
Pathologist-validated data delivered on early-stage timelines, with the rigor required to support critical program decisions.
As study requirements evolve, we adapt protocols, scope, and timelines to match your scientific direction. Whether your program expands, pivots, or accelerates, we are built to flex with it.
Scientific rigor and quality control processes are at the center of every project — delivering high-quality, reliable results from day one.
Work as one team with our scientists and pathologists — with real-time updates and meaningful dialogue.
Immediate specimen availability eliminates sourcing delays and accelerates project initiation.
Start locally and transition seamlessly across CellCarta's owned global laboratory network as your program advances.
Pathologist-validated data delivered on early-stage timelines, with the rigor required to support critical program decisions.
As study requirements evolve, we adapt protocols, scope, and timelines to match your scientific direction. Whether your program expands, pivots, or accelerates, we are built to flex with it.
The rigor and quality of your early-stage programs play a defining role in the success of your therapeutic development. Our Lake Forest laboratory offers the histopathology services needed to make rapid, confident decisions — while ensuring the transition to later-stage global programs is seamless.
Work as one team with our scientists and pathologists — with real-time updates and meaningful dialogue.
Immediate specimen availability eliminates sourcing delays and accelerates project initiation .
Scientific rigor and quality control processes are at the center of every project — delivering high-quality, reliable results from day one.
Start locally and transition seamlessly across CellCarta’s owned global laboratory network as your program advances.
Trusted by the 17 of the top 20 pharma companies
20 years supporting Phase 1, Phase 2 and Phase 3 programs
From concept to validated histopathology assay in under 3 months.
Platform Agnostic: Dako, Leica, Ventana, Sakura and now the COMET from Lunaphore.
Specialized in ADC biomarker profiling
Trusted by the 17 of the top 20 pharma companies
20 years. Supporting Phase 1, Phase 2, and Phase 3 programs.
From concept to validated histopathology assay in under 3 months.
Platform Agnostic: Dako, Leica, Ventana, Sakura and now the COMET from Lunaphore.
Specialized in ADC biomarker profiling
PBMC Processing
Same-day PBMC processing following robust SOPs across labs in NA, EU, Australia, and China.
PBMC Processing
Same-day PBMC processing following robust SOPs across labs in NA, EU, Australia, and China.
Lead Outsourcing Director, Biopharma
Biopharma Partner
Lead Outsourcing Director, Biopharma
“CellCarta was able to present a proposal in less than a week and they were ready to contract to get kits to our sites as soon as possible. They offered expedited start up without breaking the bank on costs to get the database and lab manual ready for review and sign off faster than any other central lab I've come across.”
Lead Outsourcing Director, Biopharma
“CellCarta was extremely helpful with the data analysis: great shout out to the data analysis team! The team in MTL was super fast and super professional!”
Biopharma Partner
"CellCarta’s project managers are supportive and attentive — they coordinate with your data team, CRO/CRAs, and other vendors as needed. They don't wait for us as the sponsor to bring issues up; they bring concerns to our attention and come prepared with resolution options.”
Lead Outsourcing Director, Biopharma